Market by Therapeutic Application, Technology, Treatment Type, Product, Application, and Country | Forecast 2021-2028
In its research report, Triton
has established that the stem cell market in the Middle East and Africa is
predicted to witness growth at a compound annual growth rate of 6.50% in the
calculated years of 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries considered for
analysis in this market are:
• The United Arab Emirates
• Israel
• Turkey
• South Africa
• Saudi Arabia
• Rest of Middle East & Africa
Over the years, there has been
significant growth in cancer occurrence in the United Arab Emirates. Earlier,
the Emirates Hospital Jumeirah connected with ReGen Medical Management Dubai to
initiate a novel stem cell and regenerative medical center. Moreover, the
hospital is the first to provide a range of specialty regenerative services
across the United Arab Emirates. Hence, such developments, coupled with a high
prevalence of various types of cancer, enhance the need for stem cell
therapies, in turn, fueling the progress of the stem cell market in the
Emirates.
Turkey’s stem cell research
and cancer treatment facilities have developed significantly over the years.
Moreover, several medical tourists visit the country seeking high-quality and
low-cost stem cell treatment. Additionally, the Turkey Stem Cell
Transplantation Nursing was established as a sub-committee of the Oncology
Nursing Association of the Republic of Turkey, which indicates the high growth
of stem cell therapies and research. Therefore, the rising stem cell
transplants, along with a surge in research activities, are likely to advance
the progress of the stem cell market across Turkey.
Corning Inc manufactures and
markets ceramic, specialty glasses, and related materials. Its business
segments include optical communication, life science, display technology,
environmental technologies, and specialty material. The company’s life science
segment comprise consumables such as specialty surface, along with equipment
for cell culture research, drug discovery, microbiology, and bioprocessing,
among others. It offers its products in various regions, including the Middle
East and Africa.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA STEM CELL MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1. THREAT
OF NEW ENTRANTS
2.1.2. THREAT
OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING
POWER OF BUYERS
2.1.4. BARGAINING
POWER OF SUPPLIERS
2.1.5. COMPETITIVE
RIVALRY
2.2. IMPACT
OF COVID-19 ON STEM CELL MARKET
2.3. KEY
IMPACT ANALYSIS
2.4. INDUSTRY
COMPONENTS
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. KEY
INSIGHTS
2.8. MARKET
DRIVERS
2.8.1. GROWING
AWARENESS ABOUT UMBILICAL CORD STEM CELLS
2.8.2. SURGE
IN STEM CELL RESEARCH AND DEVELOPMENT
2.8.3. RISING
DEMAND FOR REGENERATIVE MEDICINE
2.9. MARKET
RESTRAINTS
2.9.1. ETHICAL
CONCERNS ASSOCIATED WITH STEM CELLS
2.9.2. HIGH
COST OF STEM CELL PROCEDURES
2.9.3. STRINGENT
REGULATIONS IN TERMS OF STEM CELL THERAPY
2.10. MARKET
OPPORTUNITIES
2.10.1. ADVANCEMENT
IN TECHNOLOGY
2.10.2. RISK
OF ADVERSE IMMUNE REACTIONS AND COMPLICATIONS
3. MIDDLE
EAST AND AFRICA STEM CELL MARKET OUTLOOK - BY THERAPEUTIC APPLICATION
3.1. NEUROLOGICAL
DISORDERS
3.2. ONCOLOGY
DISORDERS
3.3. DIABETES
3.4. INJURIES
AND WOUNDS
3.5. ORTHOPEDIC
TREATMENTS
3.6. CARDIOVASCULAR
DISORDERS
3.7. OTHER
THERAPEUTIC APPLICATIONS
4. MIDDLE
EAST AND AFRICA STEM CELL MARKET OUTLOOK - BY TECHNOLOGY
4.1. CRYOPRESERVATION
4.2. ACQUISITION
4.2.1. STEM
CELL APHERESIS
4.2.2. STEM
CELL BONE MARROW MARKET
4.2.3. STEM
CELL UMBILICAL CORD
4.3. EXPANSION
AND SUB-CULTURE
4.4. PRODUCTION
4.4.1. STEM
CELL CULTURE
4.4.2. THERAPEUTIC
CLONING
4.4.3. IVF
5. MIDDLE
EAST AND AFRICA STEM CELL MARKET OUTLOOK - BY TREATMENT TYPE
5.1. ALLOGENEIC
STEM CELL THERAPY
5.2. AUTOLOGIC
STEM CELL THERAPY
5.3. SYNGENEIC
STEM CELL THERAPY
6. MIDDLE
EAST AND AFRICA STEM CELL MARKET OUTLOOK - BY PRODUCT
6.1. ADULT
STEM CELL
6.1.1. HEMATOPOIETIC
STEM CELL
6.1.2. NEURAL
STEM CELL
6.1.3. UMBILICAL
CORD STEM CELL
6.1.4. MESENCHYMAL
STEM CELL
6.1.5. DENTAL
STEM CELL
6.2. HUMAN
EMBRYONIC STEM CELL
6.3. PLURIPOTENT
6.4. MOUSE/RAT
NEURAL
7. MIDDLE
EAST AND AFRICA STEM CELL MARKET OUTLOOK – BY APPLICATION
7.1. REGENERATIVE
MEDICINE
7.2. DRUG
DISCOVERY AND DEVELOPMENT
8. GEOGRAPHICAL
ANALYSIS - MIDDLE EAST AND AFRICA
8.1. COUNTRY
ANALYSIS
8.1.1. ISRAEL
8.1.2. SAUDI ARABIA
8.1.3. UNITED
ARAB EMIRATES
8.1.4. TURKEY
8.1.5. SOUTH
AFRICA
8.1.5. REST
OF MIDDLE EAST & AFRICA
9. COMPANY
PROFILES
9.1. CORNING
INC
9.2. STEMCELL
TECHNOLOGIES
9.3. STRYKER
CORPORATION
9.4. BECTON
DICKINSON AND COMPANY (BD)
9.5. CYTORI
THERAPEUTICS
9.6. QIAGEN
NV
9.7. GE
HEALTHCARE
9.8. TAKARA
HOLDINGS
9.9. SMITH
& NEPHEW PLC
9.10. INTERNATIONAL
STEM CELL CORP
9.11. MILTENYI
BIOTEC
9.12. MERCK
KGAA (SIGMA ALDRICH)
9.13. THERMO
FISHER SCIENTIFIC INC
9.14. ALLCELLS
LLC
9.15. PLURISTEM
THERAPEUTICS INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.1.1. OBJECTIVES
OF STUDY
10.1.2. SCOPE
OF STUDY
10.2. SOURCES
OF DATA
10.2.1. PRIMARY
DATA SOURCES
10.2.2. SECONDARY
DATA SOURCES
10.3. RESEARCH
METHODOLOGY
10.3.1. EVALUATION
OF PROPOSED MARKET
10.3.2. IDENTIFICATION
OF DATA SOURCES
10.3.3. ASSESSMENT
OF MARKET DETERMINANTS
10.3.4. DATA
COLLECTION
10.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 4 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 5 MIDDLE EAST AND AFRICA ACQUISITION
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 6 MIDDLE EAST AND AFRICA PRODUCTION
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 7 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 8 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 9 MIDDLE EAST AND AFRICA ADULT STEM CELL
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 10 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 11 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1 MIDDLE EAST AND AFRICA STEM CELL MARKET,
2021-2028 (IN $ MILLION)
FIGURE 2 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 3 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 4 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY DIABETES, 2021-2028 (IN $ MILLION)
FIGURE 5 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)
FIGURE 6 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)
FIGURE 7 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 8 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 9 MIDDLE EAST AND AFRICA STEM CELL MARKET,
BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)
FIGURE 10 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
ACQUISITION, 2021-2028 (IN $ MILLION)
FIGURE 11 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)
FIGURE 12 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)
FIGURE 13 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)
FIGURE 14 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)
FIGURE 15 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
PRODUCTION, 2021-2028 (IN $ MILLION)
FIGURE 16 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
STEM CELL CULTURE, 2021-2028 (IN $ MILLION)
FIGURE 17 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)
FIGURE 18 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
IVF, 2021-2028 (IN $ MILLION)
FIGURE 19 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 20 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 21 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 22 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
ADULT STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 23 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 24 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
NEURAL STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 25 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 26 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 27 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
DENTAL STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 28 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 29 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
PLURIPOTENT, 2021-2028 (IN $ MILLION)
FIGURE 30 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)
FIGURE 31 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY
REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 32 MIDDLE EAST AND AFRICA STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
FIGURE 33 ISRAEL STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 34 SAUDI ARABIA STEM CELL MARKET 2021-2028 (IN $
MILLION)
FIGURE 35 UNITED ARAB EMIRATES STEM CELL MARKET
2021-2028 (IN $ MILLION)
FIGURE 36 TURKEY STEM CELL MARKET 2021-2028 (IN $
MILLION)
FIGURE 37 SOUTH AFRICA STEM CELL MARKET 2021-2028 (IN $
MILLION)
FIGURE 38 REST OF MIDDLE EAST & AFRICA STEM CELL
MARKET 2021-2028 (IN $ MILLION)